Table 1.

Cormobidities, hormones, and cardiac morphology

Variables	C	Ob	ET	ObET
SBP, mmHg	109 ± 12	110 ± 13	112 ± 14	120 ± 12
AUC, mg/dL/min	19 098 ± 2089	20 497 ± 2819	19 671 ± 3142	22 591 ± 3410b
HOMA‐IR	12 ± 4	19 ± 9b	8.6 ± 3.9	9.2 ± 5.8c
TG, mg/dL	53 ± 13	51 ± 8	59 ± 16	37 ± 12a, b
T‐Chol, mg/dL	78 ± 26	76 ± 13	77 ± 16	66 ± 18
Insulin, ng/mL	0.84 ± 0.34	1.16 ± 0.45b	0.59 ± 0.22	0.62 ± 0.37c
Leptin, ng/mL	1.09 ± 0.37	1.91 ± 0.47b	0.87 ± 0.41	0.93 ± 0.52c
HW, g	1.17 ± 0.08	1.33 ± 0.12b	1.22 ± 0.10	1.41 ± 0.23b
LVW, g	0.85 ± 0.06	0.96 ± 0.09	0.89 ± 0.07	1.03 ± 0.23b
RVW, g	0.22 ± 0.05	0.26 ± 0.03b	0.22 ± 0.02	0.27 ± 0.03b
HW/Tibia length, g/cm	0.27 ± 0.02	0.30 ± 0.02b	0.28 ± 0.02	0.32 ± 0.05b
LVW/Tibia length, g/cm	0.20 ± 0.01	0.21 ± 0.02	0.21 ± 0.02	0.23 ± 0.05b
RVW/Tibia length, g/cm	0.05 ± 0.01	0.06 ± 0.01b	0.05 ± 0.01	0.06 ± 0.01b

Data presented as means ± SD. control (C; n = 12), control submitted to an exercise training (ET; n = 14), obese (Ob; n = 10), and obese submitted to an exercise training (ObET; n = 11) rats after 32 weeks of experimental protocol. SBP, systolic blood pressure; AUC, area under the curve for glucose; HOMA‐IR, Homeostatic model assessment index TG, triglycerides; T‐Chol, total cholesterol; HW, heart weight; LVW, left ventricle weight; RVW, right ventricle weight; Two‐way ANOVA for independent samples and Bonferroni post hoc test.

^a P < 0.05 – C versus Ob.

^b P < 0.05 – ET versus ObET.

^c P < 0.05 – Ob versus ObET.